Your search returned 3 results.

Results
	1.	Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [electronic resource] by Beltràn, Miquel Colomer, Ramon Producer: 20021227 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004. [electronic resource] by Alsina, Maria Marcos-Gragera, Rafael Capdevila, Jaume Buxó, Maria Ortiz, Rosa Maria Barretina, Pilar Vilardell, Loreto Brunet, Joan Beltran, Miquel Izquierdo, Ángel Producer: 20120306 In: Cancer epidemiology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast. [electronic resource] by Lopez-Bonet, Eugeni Pérez-Martínez, Maria Carmen Martin-Castillo, Begoña Alonso-Ruano, Miguel Tuca, Francesc Oliveras-Ferraros, Cristina Cufí, Sílvia Vazquez-Martin, Alejandro Beltràn, Miquel Bernadó, Luis Menendez, Javier A Producer: 20110505 In: Breast cancer research and treatment vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)